Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbal combination versus spironolactone + cyproterone for hirsutism in polycystic ovary syndrome
IRCT2016062121653N7Phase 2Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of portulaca oleracea extract, vitex agnus-castus, spironolactone and cyproterone in polycystic ovary syndrome (PCOS) and hirsutism (2 arms), sponsored by Jahrom University of Medical Sciences. Primary endpoint: Change in hirsutism severity. Started Jan 2018; status: completed.
02
Drugs
portulaca oleracea extractvitex agnus-castusspironolactonecyproterone
03
Conditions
polycystic ovary syndrome (PCOS)hirsutism
Beyond the preview
Go deeper on IRCT2016062121653N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016062121653N7.